QMS Medical Allied Services Ltd
Incorporated in 2017, QMS Medical Allied Services Ltd is a manufacturer and distributor of medical devices[1]
- Market Cap ₹ 152 Cr.
- Current Price ₹ 78.5
- High / Low ₹ 113 / 69.0
- Stock P/E 16.9
- Book Value ₹ 53.2
- Dividend Yield 0.64 %
- ROCE 20.7 %
- ROE 12.5 %
- Face Value ₹ 10.0
Pros
Cons
- Promoter holding has decreased over last quarter: -5.56%
- Company has a low return on equity of 12.4% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 52 | 73 | 122 | 146 | 104 | 122 | 145 | 155 | |
| 0 | 47 | 63 | 105 | 130 | 93 | 104 | 121 | 132 | |
| Operating Profit | 0 | 5 | 10 | 17 | 17 | 11 | 18 | 23 | 24 |
| OPM % | 12% | 9% | 13% | 14% | 11% | 11% | 15% | 16% | 15% |
| 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | |
| Interest | 0 | 0 | 1 | 1 | 2 | 2 | 3 | 6 | 8 |
| Depreciation | 0 | 0 | 0 | 1 | 1 | 1 | 3 | 3 | 3 |
| Profit before tax | 0 | 4 | 9 | 15 | 14 | 9 | 12 | 14 | 13 |
| Tax % | 0% | 30% | 28% | 27% | 26% | 27% | 26% | 28% | |
| 0 | 3 | 6 | 11 | 11 | 6 | 9 | 10 | 9 | |
| EPS in Rs | 19.15 | 26.63 | 26.07 | 3.31 | 4.66 | 5.40 | 4.65 | ||
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 10% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 15% |
| 3 Years: | 0% |
| TTM: | 15% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 11% |
| 3 Years: | 2% |
| TTM: | 1% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -19% |
| 1 Year: | -26% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 19% |
| 3 Years: | 12% |
| Last Year: | 13% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.01 | 0.01 | 3 | 4 | 4 | 18 | 18 | 18 | 19 |
| Reserves | 0 | 3 | 6 | 17 | 27 | 53 | 61 | 70 | 84 |
| 0 | 5 | 12 | 20 | 32 | 26 | 2 | 28 | 83 | |
| 5 | 10 | 12 | 20 | 19 | 22 | 54 | 73 | 23 | |
| Total Liabilities | 5 | 18 | 33 | 60 | 82 | 118 | 135 | 189 | 208 |
| 0 | 0 | 3 | 10 | 8 | 25 | 24 | 22 | 25 | |
| CWIP | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 3 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 48 | 46 |
| 5 | 18 | 30 | 50 | 75 | 91 | 108 | 115 | 138 | |
| Total Assets | 5 | 18 | 33 | 60 | 82 | 118 | 135 | 189 | 208 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| 0 | 0 | 4 | 2 | -2 | -8 | 1 | 18 | |
| 0 | -0 | -4 | -8 | 2 | -25 | -2 | -48 | |
| 0 | 0 | 0 | 7 | 0 | 32 | -1 | -2 | |
| Net Cash Flow | 0 | 0 | 1 | 1 | 1 | -1 | -1 | -32 |
| Free Cash Flow | 0 | 0 | 1 | -6 | -2 | -9 | 1 | 18 |
| CFO/OP | 200% | 34% | 44% | 34% | 11% | -47% | 26% | 98% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 411 | 56 | 56 | 69 | 105 | 137 | 124 | 104 |
| Inventory Days | 22,891 | 76 | 108 | 82 | 80 | 140 | 172 | 176 |
| Days Payable | 26,124 | 75 | 78 | 73 | 56 | 91 | 90 | 74 |
| Cash Conversion Cycle | -2,822 | 58 | 86 | 77 | 129 | 187 | 205 | 206 |
| Working Capital Days | -91 | 20 | 27 | 28 | 57 | 138 | 244 | 224 |
| ROCE % | 121% | 65% | 54% | 30% | 14% | 17% | 21% |
Insights
In beta| Mar 2024 | Mar 2025 | |
|---|---|---|
| Number of B2B Health Camps Number |
|
|
| Number of Cities Presence Number |
||
| Number of Employees (Total Workforce) Number |
||
| Number of Healthcare Professionals (HCPs) Engagement Lakhs |
||
| Number of Institutional Clients Number |
||
| Number of Patient Service Programs (PSPs) Number |
||
| Number of Patients Tracked in Digital Ecosystem Lakhs |
||
| Number of SKUs Number |
||
| Serviceable Pin Codes Number |
||
Documents
Announcements
-
General Updates
27 March 2026 - QMS Medical Allied Services filed March 25, 2026 in-principle application to migrate from NSE Emerge to NSE Main Board and is pending approval.
-
Trading Window
27 March 2026 - Trading window closed from 1 April 2026 until 48 hours after audited results for year/half-year ended 31 Mar 2026.
-
Outcome of Board Meeting
25 March 2026 - Approved Draft IM for migration from NSE Emerge to NSE Main Board, March 25, 2026.
-
General Updates
25 March 2026 - Annual Secretarial Compliance Report for FY ended March 31, 2025 submitted March 25, 2026.
-
Press Release
16 March 2026 - QMS appoints Himani Pruthi as Strategy & Marketing Business Unit Head, effective March 16, 2026.
Annual reports
Concalls
-
Feb 2026TranscriptAI SummaryPPT
-
Nov 2025Transcript PPT
-
Aug 2025TranscriptPPT
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Sep 2023Transcript PPT
Business Overview:[1]
QMASL does marketing and distribution of medical products and medical education services to clinics, pharma, medical companies and also to individual users. These devices are sold directly in the brand of the manufacturer and are sold under the brand name Q Devices. Company manages the distribution for other brands viz. 3M, Heine, Rossmax, etc.